P929: CIRCULATING TUMOR DNA ASSESSMENT IMPROVES PROGNOSTIC PREDICTION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING IXAZOMIB, LENALIDOMIDE, AND DEXAMETHASONE

Yasunori Kogure, Hiroshi Handa, Yuta Ito, Masaki Ri, Yuichi Horigome, Masaki Iino, Yoriko Harazaki, Takahiro Kobayashi, Masahiro Abe, Tadao Ishida, Shigeki Ito, Hiromi Iwasaki, Junya Kuroda, Hirohiko Shibayama, Kazutaka Sunami, Hiroyuki Takamatsu, Hideto Tamura, Toshiaki Hayashi, Kiwamu Akagi, Tomohiro Shinozaki, Takahiro Yoshida, Ikuo Mori, Shinsuke Iida, Takahiro Maeda, Keisuke Kataoka

Open source

DOI
10.1097/01.hs9.0000970620.26657.64
Published
2023-08
Container
HemaSphere
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/01.hs9.0000970620.26657.64,
  title = {P929: CIRCULATING TUMOR DNA ASSESSMENT IMPROVES PROGNOSTIC PREDICTION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING IXAZOMIB, LENALIDOMIDE, AND DEXAMETHASONE},
  author = {Yasunori Kogure and Hiroshi Handa and Yuta Ito and Masaki Ri and Yuichi Horigome and Masaki Iino and Yoriko Harazaki and Takahiro Kobayashi and Masahiro Abe and Tadao Ishida and Shigeki Ito and Hiromi Iwasaki and Junya Kuroda and Hirohiko Shibayama and Kazutaka Sunami and Hiroyuki Takamatsu and Hideto Tamura and Toshiaki Hayashi and Kiwamu Akagi and Tomohiro Shinozaki and Takahiro Yoshida and Ikuo Mori and Shinsuke Iida and Takahiro Maeda and Keisuke Kataoka},
  year = {2023},
  journal = {HemaSphere},
  doi = {10.1097/01.hs9.0000970620.26657.64},
  url = {https://doi.org/10.1097/01.hs9.0000970620.26657.64}
}

RIS

TY  - JOUR
TI  - P929: CIRCULATING TUMOR DNA ASSESSMENT IMPROVES PROGNOSTIC PREDICTION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING IXAZOMIB, LENALIDOMIDE, AND DEXAMETHASONE
AU  - Yasunori Kogure
AU  - Hiroshi Handa
AU  - Yuta Ito
AU  - Masaki Ri
AU  - Yuichi Horigome
AU  - Masaki Iino
AU  - Yoriko Harazaki
AU  - Takahiro Kobayashi
AU  - Masahiro Abe
AU  - Tadao Ishida
AU  - Shigeki Ito
AU  - Hiromi Iwasaki
AU  - Junya Kuroda
AU  - Hirohiko Shibayama
AU  - Kazutaka Sunami
AU  - Hiroyuki Takamatsu
AU  - Hideto Tamura
AU  - Toshiaki Hayashi
AU  - Kiwamu Akagi
AU  - Tomohiro Shinozaki
AU  - Takahiro Yoshida
AU  - Ikuo Mori
AU  - Shinsuke Iida
AU  - Takahiro Maeda
AU  - Keisuke Kataoka
PY  - 2023
JO  - HemaSphere
DO  - 10.1097/01.hs9.0000970620.26657.64
UR  - https://doi.org/10.1097/01.hs9.0000970620.26657.64
ER  - 

APA

Kogure, Y., Handa, H., Ito, Y., Ri, M., Horigome, Y., Iino, M., Harazaki, Y., Kobayashi, T., Abe, M., Ishida, T., Ito, S., Iwasaki, H., Kuroda, J., Shibayama, H., Sunami, K., Takamatsu, H., Tamura, H., Hayashi, T., Akagi, K., Shinozaki, T., Yoshida, T., Mori, I., Iida, S., Maeda, T., & Kataoka, K. (2023). P929: CIRCULATING TUMOR DNA ASSESSMENT IMPROVES PROGNOSTIC PREDICTION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING IXAZOMIB, LENALIDOMIDE, AND DEXAMETHASONE. HemaSphere. https://doi.org/10.1097/01.hs9.0000970620.26657.64

Source records